NRI News 24x7: ZIM Laboratories Limited to List on BSE Main Board on June 8, 2018

  • ZIM is amongst a few companies globally to have developed and commercialized the oral film technology.
  • The first Indian company to manufacture multi-layer thin films – that contain more than one API on a single thin strip.
  • Company to get listed on BSE Mainboard on June 08, 2018.
  • The book value price of ZIM is Rs. 160/-  per equity share
ZIM Laboratories Limited (ZIM) – is a unique R&D centered pharmaceutical company focused on developing and supply of complex generics products based on proprietary  Novel Drug Delivery Solutions (NDDS).

ZIM got listed on OTC Exchange of India in 1994, following the SEBI guidelines the company will be listing on BSE and will have a price discovery as per trading on the bourses.

Original Article

Popular posts from this blog

ZIMLab's Dr.Nidhi Sapkal delivered talk on "Technology development of Bi/Multilayer thin films" at International Conference on Pharmaceutical Development and Technology,Osaka, Japan.

ZIM Lab announces approval for Vitamin D3 Orally Disintegrating Film

ZIM Laboratories’ Clonazepam Orally Disintegrating Strips Receive Market Approval